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Abstract
Peroxisome proliferator-activated receptor- coactivator-1 (PGC-1) is highly expressed in brown adipose tissue (BAT) and plays
an important role in adaptive thermogenesis. The aim of this study was to assess the acute effect of a 3-adrenergic agonist
(Trecadrine) and leptin on the expression of PGC-1 and PPAR2 mRNA in BAT. Trecadrine produced a marked increase
(4.5-fold) in PGC-1 mRNA compared to controls (P0.001) without changes in PPAR2 mRNA, whereas leptin administration
did not alter either PGC-1 or PPAR2 expression. These results show that selective stimulation of the 3-adrenoceptor rapidly
upregulates the expression of PGC-1 in brown adipocytes without a concomitant increase in PPAR2. Moreover, our results show
that PGC-1 and PPAR2 expression in BAT seems not to be acutely regulated by leptin. © 2001 Elsevier Science Ireland Ltd.
All rights reserved.
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1. Introduction
Adaptive thermogenesis is an important component
of energy homeostasis and a physiological defence
against obesity (Lowell and Spiegelman, 2000). Brown
adipose tissue (BAT) is of special interest in the study
of adaptive thermogenesis because is the only tissue
that works exclusively as a thermogenic organ due to its
abundance of mitochondria, with ability to uncouple
the oxidative phosphorylation through uncoupling
protein (UCP) (Ricquier and Bouillaud, 2000). In this
context, it has been described that genetic ablation of
BAT produces obesity in mice (Lowell et al., 1993).
Peroxisome proliferator-activated receptor- (PPAR)
are nuclear receptors strongly involved in adipogenesis
and thermogenesis. Moreover, it has been described
that these nuclear receptors are transcription factors
controlling positively the expression of UCPs in BAT
(Kelly et al., 1998). The PPAR coactivator-1 (PGC-1)
is a coactivator of PPAR, NRFs, TR and RXR
highly expressed in BAT, but also in skeletal muscle,
heart, kidney and brain. PGC-1 plays an important role
in the expression of genes encoding proteins involved in
adaptive thermogenesis through increases in the tran-
scriptional activity of the above mentioned nuclear
receptors (Puigserver et al., 1998; Wu et al., 1999).
Thermogenesis in BAT is primarily mediated by the
sympathetic nervous system (SNS) through -adrener-
gic receptors (-AR) (Himms-Hagen, 1990). 3-AR is
the major -AR subtype expressed in rodent BAT
(D’Allaire et al., 1995) and its selective activation in-
duces the expression of UCP1 with no clear effect on
UCP2 and UCP3 expression (Puigserver et al., 1996;
Savontaus et al., 1998; Yoshitomi et al., 1998; Go´mez-
Ambrosi et al., 1999). It has been reported that -AR
activation by isoproterenol, a non-selective  agonist,
increases the expression of PGC-1 mRNA in HIB 1B
brown adipocytes differentiated in culture (Puigserver
et al., 1998). It has also been published that in vivo
selective 3-AR stimulation induces the expression of
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PGC-1 in skeletal muscle in mice (Boss et al., 1999).
However, there is no evidence of in vivo regulation of
PGC-1 mRNA expression in BAT by -AR agonists or
selective 3-AR agonists.
Leptin, the product of the ob gene, is an adipocyte-
derived hormone which plays an important role in the
energetic balance through regulation of food intake and
energy expenditure (Ahima and Flier, 2000). The mech-
anism of increased energy expenditure by leptin appears
to involve long-term increased expression of UCP1 in
BAT (Scarpace et al., 1997). However, this increase
does not take place acutely (Go´mez-Ambrosi et al.,
1999). The leptin-mediated stimulation of thermogene-
sis seems to be dependent on sympathetic innervation
providing evidence of the existence of a loop involving
SNS activity and leptin (Haynes et al., 1997) where
PGC-1 could be involved.
In this study, we assessed the acute effect of in-
traperitoneal administration of either a 3-AR agonist
or leptin on the expression of PGC-1 and PPAR2
mRNA in BAT of fasted rats and their possible relation
with some indicators of thermogenesis and lipolysis.
2. Materials and methods
2.1. Animals and procedures
Five-month-old male Wistar rats weighing 420–430 g
were housed at 251°C with 12-h light cycle (8:00–
20:00 h) and fed ad libitum. Animals were fasted
overnight before drug administration. Rectal tempera-
ture of the rats was measured prior to i.p. injections of:
saline, leptin (Peprotech, London, UK; 0.25 mg/kg) or
the 3-AR agonist Trecadrine (Wasserman-Chiesi,
Barcelona/Milan; 1 mg/kg, see reference (Barrionuevo
et al., 1996) for chemical structure and pharmacological
properties). The doses tested were used based on previ-
ous experiments showing physiological effects (Pelley-
mounter et al., 1995; Go´mez-Ambrosi et al., 1999). One
hour after administration, rectal temperature and oxy-
gen consumption were measured. This time period has
been shown to detect the maximal thermogenic effect
after 3-AR agonist administration (Shih and Taberner,
1995). Animals were killed by decapitation and trunk
blood was collected. Interscapular BAT was excised,
immediately frozen in liquid nitrogen and stored at
−80°C until analysis. All experimental procedures were
performed according to the ‘Ethical principles and
guidelines for scientific experiments on animals’ of the
Swiss Academy of Medical Sciences.
2.2. Blood analyses
Serum non-esterified fatty acid (NEFA) concentra-
tions were measured by an enzymatic method (NEFA-
C, ACS-ACOD Method, Wako Chemicals, Neuss,
Germany). Glycerol levels were quantified by using an
enzymatic colorimetric method (Randox Laboratories,
Antrim, UK). Serum leptin concentrations were deter-
mined by means of a commercially available ELISA kit
(Active™ Murine Leptin ELISA, Diagnostic System
Laboratories, Webster, TX, USA).
2.3. Oxygen consumption and rectal temperature
Oxygen consumption was assessed by means of a
Jacketed Oxygen Consumption Chamber (Harvard Ap-
paratus, Edenbridge, UK). Rectal temperature was
measured before and 1 h after drug administration by a
rectal probe (Yellow Springs Instruments, Yellow
Springs, OH, USA) connected to a Panlab thermometer
pb 0331 (Panlab, Barcelona, Spain) as described previ-
ously (Go´mez-Ambrosi et al., 1999).
2.4. Semi-quantitatie reerse transcription-polymerase
chain reaction (RT-PCR)
Total RNA was isolated by the ULTRASPEC™-II
RNA ISOLATION SYSTEM (Biotecx Laboratories,
Houston, TX, USA) from 100 mg of BAT according to
the manufacturer’s instructions. The yield and quality
of the RNA were assessed by measuring absorbance at
260 and 280 nm and by electrophoresis on 1.5% agarose
gels. One microgram of RNA was used to synthesise
first-strand cDNA after 30 min at 37°C treatment with
10 units of RNase free DNase I (Boehringer Mannheim
Gmbh, Mannheim, Germany),. The RT reaction was
carried out in a volume of 20 l containing 50 mM
Tris–HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM
dithiotreitol, 100 ng of random hexamers (Boehringer
Mannheim), 1 mM each dNTP (Bioline, London, UK),
20 units of RNase inhibitor (Promega, Madison, WI,
USA), 200 units of M-MLV RT (GIBCO BRL, Life
Technologies, Gaithersburg, MD, USA) and incubated
at 37°C for 60 min. The enzyme was inactivated by
heating at 95°C for 5 min. Four microlitres from the
RT reaction were amplified in a 50 l reaction mixture
containing 40 ng of each primer, 16 mM (NH4)2SO4, 67
mM Tris–HCl (pH 8.8), 2 mM MgCl2, 0.1% Tween-20,
0.2 mM each dNTP and 1 unit of BIOTAQ™ poly-
merase (Bioline). Primers used to amplify PGC-1
cDNA (GenBank AB025784) were 5-CCTTTCT-
GAACTTGATGTGA-3 (sense, 146–165) and 5-AT-
GCTCTTTGCTTTATTGCT-3 (antisense, 603–622),
PPAR2 (GenBank Y12882) 5-TCTGATTATGGGT-
GAAACTC-3 (sense, 43–62) and 5-TTTC-
TACTCTTTTTGTGGATC-3 (antisense, 592–612)
and -actin (GenBank J00691) 5-TCTACAAT-
GAGCTGCGTGTG-3 (sense, 1599–1618) and 5-
GGTCAGGATCTTCATGAGGT-3 (antisense,
2357–2376). Primers for PGC-1 and PPAR2 were
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designed using the Oligo® 4.05 Primer Analysis Software
(National Biosciences, Inc., Plymouth, MN, USA).
cDNA was amplified for 34 (PGC-1), 43 (PPAR2) and
25 cycles (-actin), using the following parameters: 94°C
for 30 s, 52°C (PGC-1), 51°C (PPAR2) and 59°C
(-actin) for 30 s and 72°C for 30 s, with a final extension
step at 72°C for 7 min. Although 43 cycles may seem to
be a high number of cycles of amplification, it has been
reported that during fasting, the otherwise elevated
expression of PPAR2 in fat is dramatically reduced
(Vidal-Puig et al., 1996). Amplifications were linear
under these conditions (Fig. 1) and were carried out in
a GeneAmp® PCR System 2400 (Perkin Elmer, Norwalk,
CT, USA). Primers and conditions used for UCP1
mRNA quantification were the same as described previ-
ously (Go´mez-Ambrosi et al., 1999). All PCR reactions
for each gene were performed at the same time and with
the same batch of Taq polymerase in order to reduce
variations in the efficiency of PCR. The amplified prod-
ucts were resolved in a 1.5% agarose gel with ethidium
bromide. Levels of mRNA were expressed as the ratio
of signal intensity for PGC-1 or PPAR2 relative to that
for -actin. PCR bands intensity were determined by
densitometric analysis with the Gel Doc 1000 UV fluores-
cent gel documentation system and Molecular Analyst
1.4.1 software for quantitation of images (Bio-Rad,
Hercules, CA, USA). The identity of PCR product
amplifications was demonstrated after digestion with two
restriction enzymes, yielding the predicted fragments in
all the cases.
2.5. Statistical analysis
All results are expressed as meanSE. Data were
analysed using a one-way ANOVA followed by Fisher’s
LSD posthoc test. Pearson’s correlation coefficient (r)
was computed to explore the correlations between two
variables. The calculations were performed using the
SPSS/Windows version 7.5.2S statistical package (SPSS,
Chicago, IL, USA). A P value lower than 0.05 was
considered statistically significant.
3. Results
3.1. Effects on blood biochemistry and indicators of
thermogenesis
The 3-AR agonist Trecadrine produced a marked
lipolytic effect after acute administration as evidenced by
the increase observed in circulating concentrations of
NEFA and glycerol. Leptin did not significantly alter
either NEFA or glycerol levels. Trecadrine-induced lipol-
ysis was accompanied by a rise in rectal temperature and
whole body oxygen consumption, as well as by an
elevation of UCP1 mRNA expression in BAT. Leptin
produced a rise in rectal temperature, but did not affect
oxygen consumption or UCP1 mRNA expression despite
a 20-fold increase in serum leptin concentrations (Table
1).
Fig. 1. Effects of the number of PCR cycles on the amplification of the cDNAs for -actin (A), PGC-1 (B) and PPAR2 (C) synthesised after
RNA obtained from interscapular BAT. Top, representative photographs of PCR products at different numbers of amplification cycles; bottom,
band intensities were quantified by using Gel Doc 1000 UV fluorescent gel documentation system and Molecular Analyst 1.4.1 software (Bio-Rad)
after ethidium bromide electrophoresis.
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Table 1
Serum analyses and thermogenic indicators of animals treated with
saline, the 3-AR agonist Trecadrine and leptina
TrecadrineSaline Leptin
1.240.07bNEFAh (mmol/l) 1.000.060.930.11
Glycerol (mmol/l) 0.330.02 0.580.04d 0.280.03g
Leptin (ng/ml) 0.810.251.280.51 22.021.12d,g
0.120.12 0.800.30b 0.740.10bTemperature change
(°C)
Oxygen consumption 0.710.05 1.090.04d 0.840.08e
(ml/g per hour)
BAT UCP1 mRNA 1.000.15 1.710.11c 0.830.24f
(relative units)






g P0.001 versus control and Trecadrine treated groups, respec-
tively by one-way ANOVA and Fisher’s LSD posthoc test.
h Non-esterified fatty acids.
mogenic cellular pathways of BAT. This activation was
confirmed by the marked stimulation of lipolysis and
thermogenesis elicited by Trecadrine in this short pe-
riod of time. An in vivo induction of PGC-1 mRNA in
skeletal muscle after 3-AR treatment has also been
described (Boss et al., 1999). However, this effect is
likely to be indirect, given the fact that skeletal muscle
does not seem to express physiologically significant
amounts of 3-AR (Evans et al., 1996). Boss et al.
(1999) have suggested that PGC-1 expression in muscle
could be induced by NEFA. In this sense, we have
found an association between NEFA and PGC-1
mRNA expression in BAT, suggesting that NEFA may
induce the expression of PGC-1 in several tissues in
addition to muscle.
It is known that 3-AR agonists produce hypertro-
phy of BAT (Ghorbani et al., 1997) and hypertrophy of
adipose tissue is mediated by PPAR, at least in white
adipose tissue (Kubota et al., 1999). Also, Gros et al.
(1999) have recently reported that expression of the
3-AR in CHO cells increases the expression of PPAR.
Moreover, exposure of rats to cold, which in turn
3.2. Effects on PGC-1 and PPAR2 mRNA expression
in BAT
Trecadrine induced a 4.5-fold increase in PGC-1
mRNA expression in BAT (Fig. 2) 1 h after i.p. admin-
istration (P0.001). However, PPAR2 mRNA levels
were not significantly modified. Levels of PGC-1 and
PPAR2 mRNA remained unaltered after acute leptin
administration.
Pearson’s correlation coefficient showed a statistically
significant linear relationship between PGC-1 mRNA
expression in BAT and UCP1 mRNA expression in
BAT, circulating concentrations of NEFA and oxygen
consumption (Fig. 3).
4. Discussion
PGC-1 is a coactivator deeply involved in adaptive
thermogenesis regulating the transcriptional activity of
PPAR and other nuclear receptors (Puigserver et al.,
1998). In this sense, PGC-1 controls the expression of
UCPs and turns on the biogenesis of mitochondria (Wu
et al., 1999).
It has been shown previously that non-selective -AR
agonists induce the expression of PGC-1 in cultured
HIB 1B brown adipocytes after 6 h of stimulation and
that -AR may mediate the effect of cold exposure on
the induction of PGC-1 (Puigserver et al., 1998). Our
results constitute the first evidence of the rapid (1 h) in
vivo induction of PGC-1 mRNA expression in BAT by
selective 3-AR stimulation. This finding seems to indi-
cate that PGC-1 is one of the first molecules which are
upregulated when it is necessary to activate the ther-
Fig. 2. Relative levels of PPAR2 and PGC-1 mRNA in BAT of
fasted rats treated acutely with the 3-AR agonist Trecadrine, leptin
or saline: (A) photographs show sets of PCR products from BAT of
individual rats (n=5 per group). Size of PCR products are indicated.
Left side lanes show a weight marker (100 Base-Pair Ladder, Pharma-
cia-Biotech, Uppsala, Sweden); (B) densitometric quantitation of
PPAR2 and PGC-1 mRNA expression in saline (C, white bar),
Trecadrine (T, black bar) and leptin (L, grey bar) treated groups.
Bars represent the meanSE of the ratio between PPAR2 and
PGC-1 to -actin. The expression of PPAR2 and PGC-1 in control
rats was assumed to be 1. ***P0.001 versus saline- or leptin-treated
animals by ANOVA and Fisher’s LSD.
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Fig. 3. Scatter diagrams showing the positive correlation found
between PGC-1 mRNA expression in BAT and circulating concentra-
tions of NEFA, oxygen consumption and UCP1 mRNA expression
in BAT of fifteen male fasted rats, 1 h after i.p. administration of
saline (), Trecadrine () or leptin (). Pearson’s correlation
coefficient and P values are indicated.
found between expression of PGC-1 and indicators of
thermogenesis such as UCP1 expression in BAT and
whole body oxygen consumption.
The PGC-1 is reduced in fasting and elevated upon
refeeding (Wu et al., 1999). Therefore, we reasoned that
leptin may be a candidate molecule to explain the
observed changes. However, acute leptin treatment did
not affect levels of PGC-1 in BAT. Leptin has been
shown to increase lipolysis (Fru¨hbeck et al., 1998) and
thermogenesis (Scarpace et al., 1997). In this study,
leptin did not stimulate lipolysis probably due to the
low dose administered given the fact that higher doses
are necessary to induce lipolysis in vivo (Fru¨hbeck et
al., 1998). Leptin-mediated long-term thermogenesis
has been described to take place after several days by
upregulation of UCP1 (Scarpace et al., 1997). However,
this effect is not observed acutely and other mecha-
nisms such as upregulation of UCP3 in skeletal muscle
have been proposed to explain the short-term rise in
temperature induced by leptin (Go´mez-Ambrosi et al.,
1999). These observations and the lack of effect of
leptin in the expression of PGC-1 seems to indicate that
the thermogenic activation of BAT by leptin is SNS-
mediated and is only detected after long-term
treatment.
There is no evidence of the effect of leptin on PPAR
expression in BAT and the results concerning white
adipose tissue are contradictory, since both upregula-
tion (Qian et al., 1998) and downregulation have been
found (Sanigorski et al., 2000).
In conclusion, the present study shows that adminis-
tration of a selective 3-AR agonist induces a rapid
upregulation of PGC-1 mRNA expression in BAT of
fasted rats in parallel to stimulating thermogenesis and
lipolysis, without a concomitant increase in PPAR2
mRNA. Moreover, our results indicate that PGC-1 and
PPAR2 expression in BAT seems not to be acutely
regulated by leptin.
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